Analystreport

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) had its price target raised by analysts at Guggenheim from $44.00 to $50.00. They now have a "buy" rating on the stock.

Adaptive Biotechnologies Corporation  (ADPT) 
Last adaptive biotechnologies corporation earnings: 2/26 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: adhc.com